Microfluidic Organ-on-Chip Drug Testing Market

FMI analysis revealed the organ-on-chip drug testing market was valued at USD 141.5 million in 2025. The industry is expected to cross USD 168.0 million in 2026 at a CAGR of 18.70% during the forecast period. Liver-on-chip is poised to dominate by Organ Model with 31.0% share in 2026, and Pharmaceutical and biotechnology companies are expected to lead by End User through 2036.